ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2471

What Are the Reasons of Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity and What Is the Impact of This Discordance on Remission, Function and Structure at 1 Year?

Cécile Gaujoux-Viala1, Nathalie Rincheval2, Laure Gossec3, Francis Guillemin4, Maxime Dougados5, Jean-Pierre Daures6 and Bernard Combe7, 1Rheumatology Department, University Hospital of Nîmes and EA2415, Montpellier University, Nîmes, France, 2Biostatistic, EA 2415, Epidemiology unit, Montpellier, France, 3Paris 06 University and AP-HP, Hôpital Pitié Salpêtrière, Paris, France, 4University of Lorraine, Nancy, France, 5Paris Descartes University, Paris, France, 6EA2415, Nîmes, France, 7Département Rhumatologie, Hôpital Lapeyronie, Montpellier, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients and physicians often differ in their perceptions of rheumatoid arthritis (RA) disease activity, as quantified by the patient’s global assessment (PGA) and by the evaluator’s global assessment (EGA). The quest for understanding the reasons for discrepancies in evaluations of disease activity becomes particularly important in the context of recent recommendations that define Boolean-based ACR EULAR remission as the treatment target.  The objectives of this study were 1) to explore the extent and reasons for this discordance 2) to determine if this discordance at baseline is associated with RA outcomes at 1 year (remission, function and structure) in early arthritis (EA) in daily clinical practice.

Methods: -Patients: from the French cohort of EA ESPOIR (at least 2 swollen joints for less than 6 months, DMARD naïve), fulfilling the ACR-EULAR criteria for RA at baseline -Analyses: At baseline, agreement between PGA and EGA (Bland-Altman plot) was assessed. Multivariate linear regression was used to determine the patient and EA features independently associated with discordance (calculated as PGA – EGA). Logistic regression was used to analyze discordance as│PGA – EGA│≥20. Multivariate logistic models were used to determine if discordance at baseline is associated with remissions (Boolean, SDAI and DAS28), functional stability (HAQ≤0.5 and deltaHAQ≤0.25) and absence of radiographic progression (delta Sharp score<1) after 1 year of follow-up.

Results: In 645 patients with ERA (mean age=48.8±12.2 years, 77% female, 48.7% ACPA +) agreement was better at both ends of the spectrum, especially for patients with high disease activity. The direction of the discrepancy usually points toward a higher rating by the patients than by physicians themselves. Evaluation of disease activity yielded discordant scores between the patients and their physicians in 30% of our cohort: 153 patients (24%) had higher PGA scores, 41 patients (6%) had higher EGA scores, and 451 patients (70%) had concordant PGA and EGA scores (│PGA – EGA│<20). In multivariate linear regression center-adjusted, higher PGA has been found to be associated with absence of fulfilling ACR 1987 revised criteria for RA (p=0.0005), higher levels of fatigue (p<0.0001) and lower number of swollen joint counts (SJC) (p=0.0022). With logistic regression center-adjusted, low number of SJC (OR 95%CI=1.92 [1.26-2.91]), low mental component of the SF-36 (OR 95%CI=1.82 [1.23-2.69]) and living alone (OR95%CI=1.68 [1.09-2.58]) were associated with discordance between PGA and EGA. In multivariate analyses, discordance at baseline was not associated with remission, function and structural progression at 1 year.

Conclusion:  In early RA, the discordance between PGA and EGA is multifactorial with objective measures like low SJC and absence of ACR 1987 revised criteria for RA, but also patient reported outcomes like high level of fatigue and low mental status, and environmental factor: living alone. Discordance between PGA and EGA at baseline was not associated with RA outcomes at 1 year. Understanding the reasons for a discordant view of disease activity will help to facilitate the sharing of decision-making in the management of RA.


Disclosure: C. Gaujoux-Viala, None; N. Rincheval, None; L. Gossec, None; F. Guillemin, None; M. Dougados, None; J. P. Daures, None; B. Combe, Merck, Pfizer, Roche-Chugai, 2,Merck, Pfizer, Roche-Chugai, UCB Pharma, Bristol-Myers Squibb, Celgene, Eli Lilly, Novartis, 5,Merck, Pfizer, Roche-Chugai, UCB Pharma, Bristol-Myers Squibb, Celgene, Eli Lilly, Novartis, 8.

To cite this abstract in AMA style:

Gaujoux-Viala C, Rincheval N, Gossec L, Guillemin F, Dougados M, Daures JP, Combe B. What Are the Reasons of Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity and What Is the Impact of This Discordance on Remission, Function and Structure at 1 Year? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/what-are-the-reasons-of-discrepancies-between-patients-and-physicians-in-their-perceptions-of-rheumatoid-arthritis-disease-activity-and-what-is-the-impact-of-this-discordance-on-remission-function-an/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-are-the-reasons-of-discrepancies-between-patients-and-physicians-in-their-perceptions-of-rheumatoid-arthritis-disease-activity-and-what-is-the-impact-of-this-discordance-on-remission-function-an/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology